CIL-002

N/A

Report date: 2025/03/04 11:06:00
NME

Base Information

Drug NameCIL-002
Drug Alias NameCIL-002CIL002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesCILcare Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A